BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8433528)

  • 21. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review.
    Bosch T; Wendler T
    Ther Apher; 2001 Jun; 5(3):182-5. PubMed ID: 11467754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical analysis on thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, with plasma level of cytokine].
    Wada H; Saitoh M; Tamaki S; Masuya M; Morita K; Tabata M; Tanigawa M; Kageyama S; Tsuzi K; Ohta C
    Rinsho Ketsueki; 1990 Sep; 31(9):1537-43. PubMed ID: 2246829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura in adulthood. New aspects in their pathophysiology and therapy].
    Hollenbeck M; Grabensee B
    Dtsch Med Wochenschr; 1993 Jan; 118(3):69-75. PubMed ID: 8425461
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatic veno-occlusive disease in a case of polymyositis associated with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome.
    Ishida Y; Utikoshi M; Kurosaki M; Ohta K; Chujo T; Aoyama S; Ohsawa K; Saito K; Yokoyama H; Ohta S
    Intern Med; 1998 Aug; 37(8):694-9. PubMed ID: 9745858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.
    Myers L
    Nephrol Nurs J; 2002 Apr; 29(2):171-80; quiz 181-2. PubMed ID: 11997952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
    Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
    Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombotic microangiopathy].
    Chiurchiu C; Remuzzi G
    Nefrologia; 2003; 23 Suppl 3():13-20. PubMed ID: 12901186
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Hayward CP; Sutton DM; Carter WH; Campbell ED; Scott JG; Francombe WH; Shumak KH; Baker MA
    Arch Intern Med; 1994 May; 154(9):982-7. PubMed ID: 8179455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome].
    Krause M; Fehr J; Gmür J; Keusch G; Frick P; Oelz O
    Schweiz Med Wochenschr; 1986 Nov; 116(48):1666-74. PubMed ID: 3798063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombocytopenia due to non-immune platelet destruction.
    Harlan JM
    Clin Haematol; 1983 Feb; 12(1):39-68. PubMed ID: 6340886
    [No Abstract]   [Full Text] [Related]  

  • 31. [Kidney diseases associated with hemolytic uremic syndrome,thrombotic thrombocytopenic purpura and disseminated intravascular coagulation].
    Naruse T
    Nihon Naika Gakkai Zasshi; 1992 Jan; 81(1):73-6. PubMed ID: 1556467
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma manipulation in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.
    Remuzzi G; Ruggenenti P
    Ann Med Interne (Paris); 1992; 143 Suppl 1():19-26. PubMed ID: 1300882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center.
    Kim JW; Kim I; Oh KH; Yoon SS; Oh MD; Song YW; Heo DS; Bang YJ; Han KS; Han JS; Park S; Kim BK
    Hematology; 2011 Mar; 16(2):73-9. PubMed ID: 21418736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Familial, recurring plasma infusion dependent thrombotic thrombocytopenic purpura/hemolytic uremic syndrome].
    Litwin M; Smirska E
    Pol Merkur Lekarski; 2000 Apr; 8(46):289-90. PubMed ID: 10897656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Differential diagnosis of DIC, TTP, and HUS].
    Ozaki Y
    Rinsho Byori; 2011 Feb; Suppl 147():195-8. PubMed ID: 21761771
    [No Abstract]   [Full Text] [Related]  

  • 36. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura.
    Ruggenenti P; Noris M; Remuzzi G
    Kidney Int; 2001 Sep; 60(3):831-46. PubMed ID: 11532079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura: pathophysiology and treatment.
    Neild GH
    Kidney Int Suppl; 1998 Feb; 64():S45-9. PubMed ID: 9475488
    [No Abstract]   [Full Text] [Related]  

  • 38. [Etiopathogenesis of thrombotic microangiopathy in the light of new studies].
    Rydzewski A; Myśliwiec M
    Pol Tyg Lek; 1983 May; 38(19):619-22. PubMed ID: 6356093
    [No Abstract]   [Full Text] [Related]  

  • 39. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after bupropion treatment for smoking cessation.
    Mele L; Voso MT; Fianchi L; Leone G; Pagano L
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):77-8. PubMed ID: 12544732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.
    Bell WR; Braine HG; Ness PM; Kickler TS
    N Engl J Med; 1991 Aug; 325(6):398-403. PubMed ID: 2062331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.